Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice.
We have recently observed that oral administration of D-glucose saves animals from lipopolysaccharide (LPS)-induced death. This effect is the likely consequence of glucose-induced activation of the sodium-dependent glucose transporter-1. In this study, we investigated possible hepatoprotective effects of glucose-induced, sodium-dependent, glucose transporter-1 activation. We show that oral administration of D-glucose, but not of either D-fructose or sucrose, prevents LPS-induced liver injury, as well as liver injury and death induced by an overdose of acetaminophen. In both of these models, physiological liver morphology is maintained and organ protection is confirmed by unchanged levels of the circulating markers of hepatotoxicity, such as alanine transaminase or lactate dehydrogenase. In addition, D-glucose was found to protect the liver from alpha-amanitin-induced liver injury. In this case, in contrast to the previously described models, a second signal had to be present in addition to glucose to achieve protective efficacy. Toll-like receptor 4 stimulation that was induced by low doses of LPS was identified as such a second signal. Eventually, the protective effect of orally administered glucose on liver injury induced by LPS, overdose of acetaminophen, or alpha-amanitin was shown to be mediated by the anti-inflammatory cytokine interleukin-10. These findings, showing glucose-induced protective effects in several animal models of liver injury, might be relevant in view of possible therapeutic interventions against different forms of acute hepatic injury.
Zanobbio
Laura
L
Faculty of Pharmacy, Department of Human Morphology and Biomedical Sciences Città Studi, Università degli Studi di Milano, via Mangiagalli 31, Milan, Italy.
Palazzo
Marco
M
Gariboldi
Silvia
S
Dusio
Giuseppina F
GF
Cardani
Diego
D
Mauro
Valentina
V
Marcucci
Fabrizio
F
Balsari
Andrea
A
Rumio
Cristiano
C
D000082:Acetaminophen / Q000009:adverse effects; D000284:Administration, Oral; D053959:Alpha-Amanitin / Q000633:toxicity; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D005632:Fructose / Q000008:administration & dosage; D005688:Galactosamine / Q000009:adverse effects; D005947:Glucose / Q000008:administration & dosage*; D016753:Interleukin-10; D007413:Intestinal Mucosa / Q000378:metabolism; D008070:Lipopolysaccharides / Q000633:toxicity; D008107:Liver Diseases / Q000378:metabolism / Q000517:prevention & control*; D051379:Mice; D008810:Mice, Inbred C57BL; D015398:Signal Transduction; D051269:Sodium-Glucose Transporter 1 / Q000378:metabolism; D013395:Sucrose / Q000008:administration & dosage; D051197:Toll-Like Receptor 4 / Q000378:metabolism
D053959:Alpha-Amanitin; D008070:Lipopolysaccharides; D051269:Sodium-Glucose Transporter 1; D051197:Toll-Like Receptor 4; D016753:Interleukin-10; D005632:Fructose; D000082:Acetaminophen; D013395:Sucrose; D005688:Galactosamine; D005947:Glucose
Toxicol Sci. 2000 Apr;54(2):509-16
10774834
Med Hypotheses. 2007;69(2):361-7
17336461
Liver Int. 2006 Dec;26(10):1163-74
17105581
J Leukoc Biol. 1995 Mar;57(3):368-74
7884306
Toxicol In Vitro. 2008 Jun;22(4):961-7
18346862
J Immunol. 2008 Sep 1;181(5):3126-36
18713983
Am J Physiol Gastrointest Liver Physiol. 2001 Jan;280(1):G113-20
11123204
Exp Mol Pathol. 2003 Dec;75(3):187-93
14611809
Br J Clin Pharmacol. 1980 Oct;10 Suppl 2:373S-379S
7002191
Postgrad Med J. 2005 Mar;81(953):148-54
15749789
Am J Physiol. 1998 Sep;275(3):G387-92
9724248
Gastroenterology. 2008 Oct;135(4):1311-21
18700144
Gut. 2002 Dec;51(6):842-8
12427787
Liver Transpl Surg. 1999 Jan;5(1):29-34
9873089
Br J Nutr. 1984 May;51(3):517-29
6722092
Toxicon. 1998 Jan;36(1):13-24
9604278
Exp Cell Res. 2006 Oct 15;312(17):3276-86
16860318
Hepatology. 2005 Oct;42(4):871-9
16175609
Toxicology. 1999 Nov 5;138(2):103-26
10576587
Hepatology. 2008 Jan;47(1):215-24
18085707
Hepatology. 2003 Feb;37(2):324-33
12540782
J Clin Invest. 2008 Mar;118(3):1132-42
18259614
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13722-7
11717433
Blood. 2005 Oct 15;106(8):2818-26
16030185
J Gastroenterol Hepatol. 2006 Apr;21(4):682-8
16677153
Exp Toxicol Pathol. 2007 Oct;59(2):121-8
17716880
Liver Transpl Surg. 1995 Jul;1(4):210-9
9346568
Shock. 2002 Mar;17(3):210-6
11900340
Am J Clin Nutr. 1993 Nov;58(5 Suppl):748S-753S
8213606
Gut. 2000 Aug;47(2):184-91
10896908
Acta Gastroenterol Belg. 2003 Jan-Mar;66(1):7-14
12812143
Hepatology. 2002 Feb;35(2):289-98
11826401
Regul Toxicol Pharmacol. 1998 Apr;27(2):119-30
9671567
Toxicon. 1993 Dec;31(12):1513-40
8146866
Hepatology. 1995 Jun;21(6):1632-9
7768509